Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-04-027889
Filing Date
2004-02-23
Accepted
2004-02-23 15:18:14
Documents
6
Period of Report
2003-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K d10k.htm 10-K 836350
3 LIST OF SUBSIDIARIES OF REGISTRANT dex211.htm EX-21.1 1379
4 CONSENT OF ERNST & YOUNG LLP, INDEPENDENT AUDITORS dex231.htm EX-23.1 1659
5 CERTIFICATION OF THE CHIEF EXECUTIVE OFFICER PURSUANT TO SECTION 302 dex311.htm EX-31.1 7503
6 CERTIFICATION OF THE PRINCIPAL FINANCIAL OFFICER PURSUANT TO SECTION 302 dex312.htm EX-31.2 7521
7 CERTIFICATION OF THE CHIEF EXECUTIVE OFFICER AND PRINCIPAL FINANCIAL OFFICER dex321.htm EX-32.1 4122
  Complete submission text file 0001193125-04-027889.txt   860794
Mailing Address 6330 QUADRANGLE DR SUITE 240 CHAPEL HILL NC 27514
Business Address 6330 QUADRANGLE DR SUITE 240 CHAPEL HILL NC 27514 9194900012
POZEN INC /NC (Filer) CIK: 0001059790 (see all company filings)

EIN.: 621657552 | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-31719 | Film No.: 04621931
SIC: 2834 Pharmaceutical Preparations